Henry Schein's stock fetched about 25% less than it did on Thursday, but after accounting for a spinoff transaction, the shares were really down much less, closer to 5%. The company completed the separation of its global animal health business into a distinct corporate entity, with the immediate merger of that business into what will henceforth be known as Covetrus ( CVET ). As part of the spinoff, the continuing company will receive about $1.1 billion in cash that it expects to use to pay down debt. Going forward, the move will allow Schein to focus on the dental and medical market for its healthcare solutions, and the company sees great growth opportunities in those markets. Schein investors will get 0.4 shares of Covetrus for every Schein share they own, and that makes up in part for the hit to the share price of Henry Schein stock today.